Clinical Trials
35 trialsA Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Weill Medical College of Cornell University
Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures
University of Southern California
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
SynerGene Therapeutics, Inc.
PNOC028
University of California, San Francisco
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Cancer Research UK
CAN
Life University
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
PULS
Centre Leon Berard
Effect of Kava on Anxiety and Stress in Cancer Survivors
Masonic Cancer Center, University of Minnesota
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
Stanford University
MATCH
University of Texas Southwestern Medical Center
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
JS InnoPharm, LLC
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Northwell Health
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Dushu Lake Hospital Affiliated to Soochow University
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
Dosentrx Ltd.
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Laser LabCorp
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Anaeropharma Science, Inc.
SERENITY
Tetra Bio-Pharma
ACELARATE
The Clatterbridge Cancer Centre NHS Foundation Trust
RESET
University of Basel
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Oshadi Drug Administration
HIPEC
Hospital General Universitario Gregorio Marañon
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Roger Williams Medical Center
Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
Humanigen, Inc.
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours
Herlev Hospital
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood
Seattle Children's Hospital
A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours
Eisai Inc.
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Synta Pharmaceuticals Corp.
A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors
Eisai Inc.
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors
Adherex Technologies, Inc.
Study of XL418 in Adults With Solid Tumors
Exelixis
Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning
University of Luebeck
The Plenaxis® Experience Study
PRAECIS Pharmaceuticals Inc.